Circ_0000291 contributes to hepatocellular carcinoma tumorigenesis by binding to miR-1322 to up-regulate UBE2T.

[1]  D. Xiu,et al.  circEPS15 Overexpression in Hepatocellular Carcinoma Modulates Tumor Invasion and Migration , 2020, Frontiers in Genetics.

[2]  G. Brandi,et al.  Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma? , 2021, Expert opinion on investigational drugs.

[3]  L. Terracciano,et al.  Hepatocellular carcinoma: a clinical and pathological overview , 2021, Pathologica.

[4]  G. Brandi,et al.  Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma. , 2021, Cancer treatment and research communications.

[5]  Ce Li,et al.  LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma , 2021, Biomarker Research.

[6]  W. Mi,et al.  circ_0067934: A Potential Biomarker and Therapeutic Target for Hepatocellular Carcinoma. , 2020, Annals of clinical and laboratory science.

[7]  Li Liu,et al.  UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation , 2020, Journal of Experimental & Clinical Cancer Research.

[8]  Jia Cao,et al.  Identification of Hsa_circ_0104824 as a Potential Biomarkers for Breast Cancer , 2020, Technology in cancer research & treatment.

[9]  Q. Ma,et al.  Identification and analysis of circRNA-miRNA-mRNA regulatory network in hepatocellular carcinoma. , 2020, IET systems biology.

[10]  W. Fan,et al.  hsa_circ_0001955 Enhances In Vitro Proliferation, Migration, and Invasion of HCC Cells through miR-145-5p/NRAS Axis , 2020, Molecular therapy. Nucleic acids.

[11]  J. Min,et al.  The circRNA circ_0000291 acts as a sponge of microRNA 326 to regulate E26 transformation‐specific sequence‐1 expression and promote breast cancer progression , 2020, Pathology international.

[12]  F. Piñero,et al.  Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment , 2020, Cells.

[13]  X. Jia,et al.  The new function of circRNA: translation , 2020, Clinical and Translational Oncology.

[14]  Wei Hu,et al.  Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression. , 2020, Cellular signalling.

[15]  Mihye Lee,et al.  Regulatory Mechanism of MicroRNA Expression in Cancer , 2020, International journal of molecular sciences.

[16]  G. Dong,et al.  Circ‐HOMER1 enhances the inhibition of miR‐1322 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells , 2020, Journal of cellular biochemistry.

[17]  Cong-huan Shen,et al.  SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T , 2020, Aging.

[18]  Liheng Chen,et al.  Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker , 2020, Journal of cellular biochemistry.

[19]  Maoquan Li,et al.  Downregulated Circular RNA hsa_circ_0000291 Suppresses Migration And Proliferation Of Gastric Cancer Via Targeting The miR-183/ITGB1 Axis , 2019, Cancer management and research.

[20]  Wenxin Li,et al.  Up-Regulation of hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma , 2019, Front. Oncol..

[21]  Xiangnan Yu,et al.  UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma , 2019, Cancer management and research.

[22]  Jørgen Kjems,et al.  The biogenesis, biology and characterization of circular RNAs , 2019, Nature Reviews Genetics.

[23]  Qian Wang,et al.  Circbank: a comprehensive database for circRNA with standard nomenclature , 2019, RNA biology.

[24]  Ping Yang,et al.  High expression of UBE2T predicts poor prognosis and survival in multiple myeloma , 2019, Cancer Gene Therapy.

[25]  H. El‐Serag,et al.  Epidemiology and Management of Hepatocellular Carcinoma. , 2019, Gastroenterology.

[26]  Q. Pan,et al.  circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma , 2018, Cell Death & Disease.

[27]  Zhen-bo Feng,et al.  A circRNA–miRNA–mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma , 2018, Journal of Translational Medicine.

[28]  G. Brandi,et al.  Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept , 2018, Scientific Reports.

[29]  Yanlong Liu,et al.  Hsa_circ_0007534 as a blood-based marker for the diagnosis of colorectal cancer and its prognostic value. , 2018, International journal of clinical and experimental pathology.

[30]  A. Panda.  Circular RNAs Act as miRNA Sponges. , 2018, Advances in experimental medicine and biology.

[31]  Ming-yue Li,et al.  UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53. , 2017, Biochemical and biophysical research communications.

[32]  Meijuan Huang,et al.  Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer , 2017, World journal of gastroenterology.

[33]  Minghua Wu,et al.  CircRNA: functions and properties of a novel potential biomarker for cancer , 2017, Molecular Cancer.

[34]  N. Rajewsky,et al.  Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis , 2017, Molecular cell.

[35]  He-da Zhang,et al.  CircRNA: a novel type of biomarker for cancer , 2017, Breast Cancer.

[36]  J. Salzman,et al.  Detecting circular RNAs: bioinformatic and experimental challenges , 2016, Nature Reviews Genetics.

[37]  A. Jaca,et al.  The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer , 2016, Journal of Clinical Pathology.

[38]  Bin Yu,et al.  Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway , 2016, Oncology research.

[39]  Ying-jian Liang,et al.  FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling. , 2016, Cancer letters.

[40]  Hui Sun,et al.  Effects of Different Anesthetic Methods on Cellular Immune and Neuroendocrine Functions in Patients With Hepatocellular Carcinoma Before and After Surgery , 2016, Journal of clinical laboratory analysis.

[41]  Dawood B. Dudekula,et al.  CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs , 2016, RNA biology.

[42]  Liangliang Xu,et al.  The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma , 2016, Journal of Cancer Research and Clinical Oncology.

[43]  H. Ye,et al.  Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice , 2014, Oncogene.

[44]  Hui Zhang,et al.  Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker , 2012, Tumor Biology.

[45]  E. Olson,et al.  Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. , 2010, Cancer cell.

[46]  W. Filipowicz,et al.  Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.

[47]  R. DePinho,et al.  Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. , 2003, Cancer research.